基于胃类器官的皮下与原位体内CRISPR筛选鉴定胃癌抑癌基因
该研究利用胃类器官在皮下和手术原位肿瘤模型中开展体内CRISPR敲除筛选,靶向49个候选胃抑癌基因及5000个基因的全癌基因组文库,在免疫健全与缺陷小鼠及幽门螺杆菌感染与否条件下进行。Pten失活导致大肿瘤伴新生血管增加、中性粒细胞募集和T细胞排斥;Smad4/Tgfbr1/Acvr2a失活模拟早期胃癌前驱病变;幽门螺杆菌不影响突变 landscape,而调节肿瘤微环境并募集促瘤SiglecF+中性粒细胞。
要点
- 胃类器官体内CRISPR筛选可鉴定Pten、Fbxw7及TGF-β通路成员为胃癌抑癌基因。
- Pten失活促进血管生成、中性粒细胞浸润和T细胞排斥。
- Smad4/Tgfbr1/Acvr2a失活再现肠化生和代偿性增生等癌前病变。
核心结论
- 胃类器官皮下与原位体内CRISPR筛选可重复鉴定Pten、Fbxw7及TGF-β通路基因作为胃癌抑癌基因,并揭示Pten失活促血管生成和免疫排斥、TGF-β通路失活模拟癌前病变。
研究设计与样本
- 研究使用定制文库靶向49个候选胃抑癌基因及靶向5000个基因的全癌基因组文库,在免疫健全与缺陷小鼠及幽门螺杆菌感染与否条件下进行体内CRISPR敲除筛选。
主要发现
- 定制文库筛选在皮下和原位肿瘤中反复富集靶向Pten、Fbxw7及TGF-β通路基因(Smad4、Tgfbr1、Tgfbr2、Acvr2a)的sgRNA。
- Pten失活导致大肿瘤,伴新生血管增加、中性粒细胞募集和T细胞排斥。
- Smad4、Tgfbr1或Acvr2a失活产生类似早期胃癌前驱病变的表型,如肠型Alcian蓝阳性化生和代偿性增生。
- 幽门螺杆菌感染未影响肿瘤突变 landscape,但调节肿瘤微环境并募集大量促瘤SiglecF+中性粒细胞。
临床怎么用
- 该模型可解耦肿瘤遗传学与宿主因素,忠实再现胃癌关键风险因素,为研究胃癌发生和免疫微环境提供工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: CRISPR-Cas9 screening is a powerful tool for the in vivo discovery of cancer dependencies. The aim of this study was to perform in vivo CRISPR knockout screening for gastric tumor suppressors using gastric murine organoids in a subcutaneous as well as a surgical model of orthotopic tumor growth. METHODS: In vivo screening was performed using a custom library targeting 49 putative gastric tumor suppressor genes, as well as a "cancer genome-wide" library targeting 5000 genes, in immunocompetent and -deficient mice, and in the presence or absence of the gastric pathogen Helicobacter pylori. The top hits were selected for individual validation and mechanistic follow-up. RESULTS: Our custom library knockout screens revealed single-guide RNAs targeting Pten, Fbxw7, and genes encoding several components of the transforming growth factor-ß signaling pathway (Smad4, Tgfbr1, Tgfbr2, and Acvr2a) to be recurrently enriched both in subcutaneously and orthotopically growing tumors. The same, and several additional genes were identified by cancer genome-wide CRISPR screening. Ten of our top hits could be validated individually in vivo. Pten inactivation resulted in large tumors characterized by increased neo-angiogenesis, neutrophil recruitment, and T-cell exclusion. Inactivation of Smad4, Tgfbr1, or Acvr2a all produced phenotypes that were reminiscent of early gastric cancer precursor lesions such as intestinal Alcian blue-positive metaplasia and compensatory hyperplasia. Helicobacter pylori infection failed to affect the mutational landscape of tumors; rather, we found that H pylori modulates the tumor microenvironment and recruits large numbers of tumor-promoting SiglecF+ neutrophils. CONCLUSIONS: In summary, we describe here a versatile model of gastric carcinogenesis that uncouples the genetics of the tumor and the host, and that faithfully recapitulates key risk factors of the malignancy.
引用
- He J, Papa G, Azizi F, et al. Gastric Organoid-Based Ectopic and Orthotopic In Vivo CRISPR Screening for Tumor Suppressors in Gastric Cancer. Gastroenterology. 2025. PMID: 41288537. doi:10.1053/j.gastro.2025.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。